Question Bank › Undersized for what it has already been handed

Undersized for what it has already been handed

Calls Tested
498
Answered YES
14
Hit Rate
2.8%
rare by design

HealthStream, Inc. (HSTM) — this company's answers

NO on the Q3 2017 call 2017-10-24 C
The model's full reasoning — Q3 2017 call → NOWe need to determine if the transcript conveys that the company is presently too small for the business it has already been given, with all three conditions: (1) business already secured, (2) out of proportion to present size, (3) visibly growing into it now, and that results contain little of it. Let's analyze the transcript. Key points from management: - Q3 revenues up 9% to $63.6M, record. Operating income up 210%, adjusted EBITDA up 41%. Strong quarter. - Workforce Solutions: revenues up $1.6M despite $1.2M ICD-10 decline, driven by knowledge Q sales. Resuscitation solutions second. - Patient Experience: revenues down 1% but margins improved. - Provider Solutions: revenues up 58% due to Morrisey acquisition, deferred revenue write-downs, one-time adjustment, and organic growth ~15%. - New products: Nurse Residency Pathway, OB Risk program. They have shown revenue and sales orders. OB Risk selected by one of largest customers for system-wide deployment in multiyear agreement. Also top five account renewed early for five years, added knowledge Q. - They mention that these new products are small but a nice start. - They discuss challenges: macro conditions, bad debt expense increased, hospital bankruptcies. - They mention that some large accounts made purchases for HeartCode licenses in Q3, which won't repeat in Q4. That's a one-time pickup. - They discuss the Laerdal agreement expiring end of 2018, and they are signing new partners to bring new resuscitation solutions in Jan 2019. They have signed two new strategic partners in last 100 days. - They talk about transformation: moving to SaaS, e-surveys, etc., which pressures top line but improves margins. - They mention capital position strong, $123M cash, no debt, and they may deploy capital for inorganic growth. - They discuss ASC 606 compliance costs. Now, the question: Does management convey that the company is presently too small for the business it has already been given? That is, is there a situation where they have secured business that is large relative to the company, and they are working to grow into it? Look for evidence: - They have new products with sales orders, but they are described as "very small but a nice start." So not large relative to company. - The OB Risk program selected by one of largest customers, multiyear agreement.

← Back to the full HSTM analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that THE COMPANY IS PRESENTLY TOO SMALL FOR THE BUSINESS IT HAS ALREADY BEEN GIVEN — that is, does management's own account of the business make clear that real, already-secured or already-arriving business is LARGE RELATIVE TO THE COMPANY AS IT STANDS TODAY, and that the company is visibly working now to become big enough to serve it? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation with all three of the following present as a current reality: (1) THE BUSINESS IS ALREADY THE COMPANY'S, NOT SOMETHING IT STILL HAS TO WIN. Management points to demand, orders, contracts, awards, customers, programs, volumes, bookings, committed work, or activity that has already been won, already been committed by counterparties, or is already arriving — described in the past or present tense as settled fact. The form may take whatever fits the industry: work awarded and scheduled, an order book or committed volumes running ahead of current output, customers already signed and ramping, a relationship already widened into a bigger phase, output already spoken for, or business already flowing faster than the company can serve it. Interest, inquiries, pipeline, bids outstanding, market opportunity, letters of intent, or business contingent on approvals, financing, or decisions not yet made do NOT satisfy this. (2) IT IS OUT OF PROPORTION TO THE COMPANY'S PRESENT SIZE. Management conveys — directly, or plainly in substance through how it discusses the business — that what has already been secured or is already arriving is large next to the company's current level of revenue, output, capacity, headcount, or activity: enough that delivering it would leave the company noticeably bigger than the period just reported. Management may express this by comparing it to the existing business, by calling it unprecedented or the largest of its kind for this company, by describing how much the company must add in order to handle it, by noting how little of it has reached the results so far, or by discussing the strain it is putting on the organization. (3) THE COMPANY IS VISIBLY GROWING INTO IT NOW. Management describes real steps already underway or already committed to become capable of serving that business — adding capacity, facilities, or sites; hiring, training, or reorganizing; producing, stocking, or securing supply; bringing in outside capability; sequencing and scheduling delivery — treated as a central part of what the company is presently working on rather than as something contemplated, budgeted for later, or awaiting funds it does not have. Candor about the strain, cost, disorder, or difficulty of catching up strengthens rather than weakens a YES. Management should also convey, directly or plainly in substance, that the results just reported contain little of this business, because its delivery, revenue, or activity mostly lies ahead — so today's figures describe the smaller company that existed before it arrived. The essence is ONE phenomenon: an undersized company that has already been chosen or already been sent more business than it can currently carry, and is now racing to grow into it. The industry, the source of the business, and the form of the catching-up may vary widely — a manufacturer with an order book beyond its lines, a services firm with awarded work beyond its people, a resource or infrastructure company with committed offtake beyond its built capacity, a healthcare or consumer business with demand beyond its sites or supply, or a technology company with signed customers beyond its ability to onboard them all qualify if the substance is there. Answer NO if the company can comfortably serve what it has, however strong the quarter — ordinary growth inside adequate capability is not this phenomenon. NO if the forward story rests chiefly on demand strength, market size, pipeline, competitive wins still to come, hoped-for orders, or management's confidence rather than on business already secured or already arriving. NO if the secured business is routine in scale for this company — its ordinary order book, normal seasonal volume, or usual cadence of wins worked off at the usual pace — with no sense that it steps the company beyond its current level. NO if the expansion described is routine maintenance, ordinary annual investment, or normal replacement of existing capability. NO if the company is expanding chiefly in anticipation of demand it still has to win, with nothing yet committed to fill it. NO if the binding difficulty described is weak demand, competition, pricing, macro conditions, or a shortage of purchased inputs unaccompanied by business the company cannot serve. NO if the secured business is already substantially delivered and reflected in the reported results, leaving little ahead. NO if the catching-up is only planned, under study, or contingent on financing or approvals not yet obtained. NO if management is chiefly explaining cancellations, deferrals, renegotiations downward, delays, or its inability to deliver what was committed, or is cutting, consolidating, and defending weak results. NO if the situation appears only in an analyst's question, model, or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
TSSI TSS, Inc. Q4 2022 2023-04-03 D
PI Impinj, Inc. Q4 2022 2023-02-08 B+
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
EVGO EVgo, Inc. Q2 2022 2022-08-09 C+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
ALB Albemarle Corporation Q3 2018 2018-11-08 B
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

KOPN · Q4 2023 → YESThe question is whether management conveys that the company is presently too small for the business it has already been given. YES The transcript shows management describing a record $55 million backlog (up from prior years), specific $20.5 million order plus follow-ons, and expectations to ship triple the volume of weapon sites under contracts already in place. This satisfies condition (1) as secured, committed business already won and arriving.
GOGO · Q1 2016 → YESThe question is whether management conveys that the company is presently too small for the business it has already been given. YES The transcript shows management describing 2Ku aircraft awards already secured (over 1000, majority to be installed by end of 2018), with current revenue at $142M and only 75 installations this year.
FSS · Q1 2018 → YESThe question is whether management conveys that the company is presently too small for the business it has already been given. I need to check for three things:

More from the question bank

Self-authored recoveryThe company is outgrowing its own explanatioMid-period crossingsGrowing out of the old selfTheir own money on the lineWinning is getting easierAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.